Biovista expands Project Prodigy collaborations in personalized medicine

August 11, 2017Press Releases

Biovista and Hewlett Packard Enterprise to collaborate on next generation AI and Big Data Analytics to advance real-world personalized medicine at community hospital settings. CHARLOTTESVILLE, Va., Aug. 10, 2017 /PRNewswire/ — Biovista announced today that it is collaborating with HPE to advance Biovista’s Project Prodigy Big Data AI healthcare platform applied in the personalized medicine … Read More

Sarah Bush Lincoln to Use Biovista’s Project Prodigy Artificial Intelligence Engine to Identify and Validate New Therapeutic Options for Further Research

January 19, 2017Press Releases

Charlottesville, VA (PRWEB) January 19, 2017 Sarah Bush Lincoln (SBL), a hospital and health care organization that is home to more than 300,000 provider office visits per year, and Biovista announced today that they will be working together to validate novel therapeutic options generated in the real-world practice of a hospital and health center, using … Read More

Biovista announces strong preclinical results for two drugs targeting Niemann-Pick Disease Type A

January 12, 2017Press Releases

CHARLOTTESVILLE, Va. – Jan. 12, 2017 – Biovista Inc. today announced that two drugs targeting Niemann-Pick Disease Type A (NPA), have shown strong positive results in the Acid Sphingomyelinase ASM knock-out (ASMKO) mouse model. Both repositioning candidates (BVA-901A and BVA-901B) tested by the laboratory of Dr. M.D. Ledesma at the Madrid Center for Molecular Biology … Read More

Biotrend Chemikalien GmbH awards contract to Biovista Inc. for its Vizit literature search tool

November 3, 2016Press Releases, Vizit Blog

Charlottesville, VA, November 3rd, 2016 — Biovista Inc. today announced the signing of a contract with Biotrend Chemikalien GmbH1 for access to Biovista’s2 Vizit3 visual search engine. Biotrend will be offering Vizit as a free resource to visitors of its web site. Vizit is a visual search engine of PubMed articles that allows researchers and … Read More

Biovista Inc. Announces Drug Repositioning Collaboration with Astellas Pharma

December 4, 2015Press Releases

CHARLOTTESVILLE, Virginia, December 2, 2015 /PRNewswire/ — Biovista announced today that it has entered into a drug repositioning collaboration with Astellas Pharma Inc. The collaboration is focused on identifying new indications for a number of undisclosed Astellas compounds using Biovista’s Clinical Outcome Search Space (COSS) technology. “We look forward to working with the Drug Repurposing … Read More